Schedule 13D ownership disclosure

CYCLACEL PHARMACEUTICALS INC

Common Stock, $0.001 par value · CUSIP: 23254L801

Event date: 2025-02-06

Filing-level shares
39,021,180.00
Percent of class
15.84%
  • Lazar David E.Reported CIK 0001932843

    Shares: 39,021,180.00 · Class: 15.84%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-000649
Form type
SCHEDULE 13D
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Feb 28, 2025
Reporting period
Feb 06, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub